LBA57 MHC-II antigen presentation pathway as a predictive biomarker for sintilimab plus chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC).
Saved in:
| Title: | LBA57 MHC-II antigen presentation pathway as a predictive biomarker for sintilimab plus chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC). |
|---|---|
| Authors: | Yang, Y.1 (AUTHOR), Sun, J.2 (AUTHOR), Wang, Z.3 (AUTHOR), Fang, J.4 (AUTHOR), Yu, Q.5 (AUTHOR), Han, B.6 (AUTHOR), Cang, S.7 (AUTHOR), Chen, G.8 (AUTHOR), Mei, X.9 (AUTHOR), Yang, Z.10 (AUTHOR), Ma, R.11 (AUTHOR), Bi, M.12 (AUTHOR), Ren, X.13 (AUTHOR), Zhou, J.14 (AUTHOR), Li, B.15 (AUTHOR), Zhou, H.16 (AUTHOR), Wang, S.16 (AUTHOR), Xu, W.2 (AUTHOR), Peng, B.2 (AUTHOR), Zhang, L.1 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1186-S1186. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2020.08.2290 |
